Keyphrases
Chronic Exposure
100%
Adrenomedullin
100%
Morphine
100%
Opioid Peptides
100%
Neuronal Nitric Oxide Synthase (nNOS)
57%
Calcitonin Gene-related Peptide
57%
Adrenal Medulla
42%
Adrenomedullin Receptor
42%
Chronic Use
28%
Intrathecal
28%
Morphine Tolerance
28%
Inflammation
14%
Receptor Signaling
14%
Bioactivity
14%
Decreased Expression
14%
Dorsal Root Ganglion
14%
Receptor Antagonist
14%
Analgesia
14%
Study Support
14%
Bolus
14%
Dorsal Root Ganglion Neurons
14%
MRNA Level
14%
Receptor Agonist
14%
Small-sized
14%
Morphine Analgesia
14%
Medium Size
14%
Peptide Expression
14%
Thermal Hyperalgesia
14%
Chronic Morphine
14%
Spinal Dorsal Horn
14%
Intrathecal Administration
14%
Endogenous Opioid Peptides
14%
Persistent Exposure
14%
Dorsal Root Ganglia Explant
14%
Pharmacology, Toxicology and Pharmaceutical Science
Long Term Exposure
100%
Adrenomedullin
100%
Opiate Peptide
100%
Morphine
100%
Neuronal Nitric Oxide Synthase
36%
Calcitonin Gene Related Peptide
36%
Intrathecal
27%
Adrenomedullin Receptor
27%
Endorphin
9%
Receptor Agonist
9%
Thermal Hyperalgesia
9%
Inflammation
9%
Receptor Antagonist
9%
Messenger RNA
9%
Neuroscience
Morphine
100%
Opioid Peptide
100%
Adrenomedullin
100%
Calcitonin
36%
Neuronal Nitric Oxide Synthase
36%
Intrathecal
27%
Dorsal Root Ganglion
27%
Adrenal Medulla
27%
Adrenomedullin Receptor
27%
Receptor Agonists
9%
Receptor Antagonist
9%
Endorphin
9%
Hyperalgesia
9%
Messenger RNA
9%